Hemoglobin's sigmoidal oxygen-binding curve reflects positive cooperativity: binding of oxygen to one subunit increases affinity at others, enabling efficient loading in lungs and unloading in tissues. 2,3-bisphosphoglycerate, pH, and temperature shift this curve, modulating oxygen release to match tissue demand. The arterio-venous oxygen difference reflects tissue extraction.
From your study of hemoglobin cooperativity, you understand that hemoglobin is a tetramer whose four subunits communicate with each other — binding oxygen to one subunit shifts the others into a higher-affinity conformation. This positive cooperativity is what gives the oxygen-hemoglobin dissociation curve its distinctive sigmoidal (S-shaped) form rather than the simple hyperbolic curve you would see with an independent binding protein like myoglobin. The physiological significance of this shape is profound: it means hemoglobin is exquisitely sensitive to the oxygen levels it encounters in different parts of the body.
In the lungs, where the partial pressure of oxygen (PO₂) is approximately 100 mmHg, hemoglobin sits on the flat upper portion of the sigmoidal curve at roughly 97–99% saturation. This plateau means that even if lung function is somewhat impaired and alveolar PO₂ drops to 80 or even 70 mmHg, hemoglobin still loads nearly as much oxygen — a critical safety margin. In the tissues, where metabolically active cells have consumed oxygen and the local PO₂ has fallen to around 40 mmHg, hemoglobin sits on the steep portion of the curve. Here, small further decreases in PO₂ cause large amounts of oxygen to be released. The steep slope means that tissues with the highest metabolic demand (and therefore the lowest local PO₂) automatically receive the most oxygen — no central controller needed.
The curve's position can be shifted left or right by several physiological modulators, and these shifts fine-tune oxygen delivery to match local conditions. A rightward shift (decreased affinity, easier unloading) is caused by increased temperature, increased CO₂, decreased pH (more acidic conditions), and elevated 2,3-bisphosphoglycerate (2,3-BPG) — a glycolytic intermediate produced by red blood cells. All of these conditions characterize actively metabolizing tissue: exercising muscle is hot, producing CO₂, generating lactic acid, and the red blood cells passing through are making more 2,3-BPG. The rightward shift ensures that hemoglobin releases extra oxygen precisely where it is needed most. This pH-dependent shift is specifically called the Bohr effect: as CO₂ enters red blood cells and is converted to carbonic acid by carbonic anhydrase, the resulting drop in pH destabilizes the oxy-hemoglobin complex and promotes oxygen release. Conversely, in the lungs, CO₂ is exhaled, pH rises, and the leftward shift helps hemoglobin bind oxygen more avidly.
The clinical measure that captures this system's performance is the arteriovenous oxygen difference (a-vO₂ difference) — the drop in oxygen content between arterial blood leaving the heart and venous blood returning from the tissues. At rest, arterial blood carries about 20 mL O₂ per deciliter and mixed venous blood carries about 15 mL/dL, yielding an a-vO₂ difference of 5 mL/dL. During intense exercise, tissues extract far more oxygen, venous saturation drops to 20–30%, and the a-vO₂ difference can triple. This increased extraction, combined with increased cardiac output, is how the body can increase total oxygen delivery from ~250 mL/min at rest to over 3,000 mL/min during maximal exercise — a feat made possible by hemoglobin's cooperative binding and its responsiveness to the chemical environment of working tissues.